| Exceptional Therapy Services Of Louisiana, Llc | |
|
3141 Touchwood Dr, Harvey, LA 70058-1626 | |
| (281) 640-0061 | |
| (888) 512-9220 |
| Full Name | Exceptional Therapy Services Of Louisiana, Llc |
|---|---|
| Type | Facility |
| Speciality | Speech-language Pathologist |
| Location | 3141 Touchwood Dr, Harvey, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295068344 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 102041 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Exceptional Therapy Services Of Louisiana, Llc 3141 Touchwood Dr, Harvey, LA 70058-1626 Ph: (281) 640-0061 | Exceptional Therapy Services Of Louisiana, Llc 3141 Touchwood Dr, Harvey, LA 70058-1626 Ph: (281) 640-0061 |
News Archive
Dainippon Sumitomo Pharma Co., Ltd. ("DSP") and Sepracor Inc. ("Sepracor") (NASDAQ: SEPR) today announce the successful completion of the tender offer by DSP's indirect wholly-owned subsidiary, Aptiom, Inc. ("Offeror"), to acquire all outstanding shares of common stock of Sepracor for $23.00 per share in cash.
Notre Dame biologists Nicole Achee and Neil Lobo are leaders of an international $23 million research grant from the Bill & Melinda Gates Foundation. Their five-year project will generate the data required to show the effectiveness of a new paradigm in mosquito control -spatial repellency - for the prevention of two important mosquito-borne diseases: malaria and dengue fever.
An international taskforce created by a UNSW Science psychology researcher has recommended a set of neurocognitive and mental health questionnaires to harmonize the assessment of patients with long COVID.
Cancer therapies have improved - in some cases dramatically - over the past two decades, but treatment for cervical cancer has remained largely unchanged. All patients receive radiation and chemotherapy, yet despite the aggressive approach, the regimen fails in about one-third of patients with cervical cancer that has spread beyond the cervix but not outside the pelvis.
A new study published on the medRxiv* preprint server hypothesized that a monoclonal antibody that has the capability to neutralize all sarbecoviruses could also be used to target a highly conserved epitope. This conserved sequence has a high probability of remaining unchanged in SARS-CoV-2 variants.
› Verified 1 days ago
Mrs. Elizabeth Morettini, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 501 Manhattan Blvd, Harvey, LA 70058 Phone: 534-976-0004 | |
Jonell Wadlington Martin, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 501 Manhattan Blvd, Harvey, LA 70058 Phone: 504-349-8677 | |
Patrick Cronin, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 501 Manhattan Blvd, Harvey, LA 70058 Phone: 504-349-7600 | |
Isabel Sarcar, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 501 Manhattan Blvd, Harvey, LA 70058 Phone: 504-349-7600 | |
Mrs. Letrice Williams Small, M.ED.L-SLP, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1912 Bradford Pl, Harvey, LA 70058 Phone: 504-858-4722 Fax: 504-368-5999 | |
Ms. Tracey Dunn Lightfoot, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 501 Manhattan, Harvey, LA 70058 Phone: 504-544-6029 Fax: 504-349-8686 |